Clinical Trial Update: Optimization of Darunavir Therapy and Dosage Recommendations [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying darunavir therapy optimization and dosage recommendations for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)

Snippet

Sponsor: Université Catholique de Louvain | Conditions: Human Immunodeficiency Virus I Infection | Phase 4 | Status: COMPLETED